These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9793362)
1. [Candida albicans morphotypes and in vitro adhesivity to cells of the human oral mucosa in HIV-positive and AIDS patients after exposure of blastospores to fluconazole. II]. Spadari E; Arosio M; Malighetti V; Bellotti MG; Artini MZ; Spadari F; Riviera L Minerva Stomatol; 1998; 47(7-8):293-7. PubMed ID: 9793362 [TBL] [Abstract][Full Text] [Related]
2. [Candida albicans: the relationship between morphotypes and in-vitro adhesivity to the oral mucosa cells of HIV-positive and AIDS patients. I]. Malighetti V; Arosio M; Bellotti MG; Spadari E; Zambellini Artini M; Spadari F; Riviera L Minerva Stomatol; 1998 Sep; 47(9):351-9. PubMed ID: 9835741 [TBL] [Abstract][Full Text] [Related]
3. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757 [TBL] [Abstract][Full Text] [Related]
4. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A; J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125 [TBL] [Abstract][Full Text] [Related]
5. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS]. Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of adhesive properties of Candida albicans isolated from the oral cavity in HIV positive patients. Macura AB; Bort A Wiad Parazytol; 2001; 47(4):723-8. PubMed ID: 16886417 [TBL] [Abstract][Full Text] [Related]
7. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629 [TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. Jandourek A; Vaishampayan JK; Vazquez JA AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200 [TBL] [Abstract][Full Text] [Related]
10. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ; Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260 [TBL] [Abstract][Full Text] [Related]
11. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients. Woldeamanuel Y; Abate D Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299 [TBL] [Abstract][Full Text] [Related]
13. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689 [TBL] [Abstract][Full Text] [Related]
14. [Susceptibility to fluconazole and itraconazole in isolates of Candida spp. from HIV-positive and HIV-negative patients]. Bernal S; Gutiérrez MJ; Serrano MC; Chávez M; Valverde A; Quindós G; Mazuelos EM Rev Esp Quimioter; 2000 Mar; 13(1):60-3. PubMed ID: 10855026 [TBL] [Abstract][Full Text] [Related]
15. [In vitro study of oral Candida albicans in virulence from HIV-positive individuals]. Liu XS; Liu HW; Guo ZJ; Luan WM Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 May; 40(3):211-4. PubMed ID: 15938881 [TBL] [Abstract][Full Text] [Related]
16. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582 [TBL] [Abstract][Full Text] [Related]
17. Oral colonization by Candida spp. among AIDS household contacts. Milan EP; Kallás EG; Costa PR; da Matta DA; Lopes Colombo A Mycoses; 2001; 44(7-8):273-7. PubMed ID: 11714061 [TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. Maninder J; Usha A J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155 [TBL] [Abstract][Full Text] [Related]
19. [Oesophageal candidiasis: clinical and mycological analysis]. Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852 [TBL] [Abstract][Full Text] [Related]
20. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics. Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]